Orphazyme: MAA Submission According to Timeline
Research Note
2020-11-09
10:15
Redeye sees positive that arimoclomol in NPC now enters the filing stage in Europe as well. The momentum in Orphazyme’s business continues.
AH
Anders Hedlund
Disclosures and disclaimers